pleconaril has been researched along with Neonatal Sepsis in 2 studies
WIN 63843: structure given in first source
Neonatal Sepsis: Blood infection that occurs in an infant younger than 90 days old. Early-onset sepsis is seen in the first week of life and most often appears within 24 hours of birth. Late-onset occurs after 1 week and before 3 months of age.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abzug, MJ | 1 |
Michaels, MG | 1 |
Wald, E | 1 |
Jacobs, RF | 1 |
Romero, JR | 1 |
Sánchez, PJ | 1 |
Wilson, G | 1 |
Krogstad, P | 1 |
Storch, GA | 1 |
Lawrence, R | 1 |
Shelton, M | 1 |
Palmer, A | 1 |
Robinson, J | 1 |
Dennehy, P | 1 |
Sood, SK | 1 |
Cloud, G | 1 |
Jester, P | 1 |
Acosta, EP | 1 |
Whitley, R | 1 |
Kimberlin, D | 1 |
Hernández, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Phase 1 Study to Confirm the Single- and Multiple-dose Pharmacokinetics and to Evaluate Food Effect of Vapendavir in Healthy Participants and Participants With COPD[NCT05962645] | Phase 1 | 24 participants (Anticipated) | Interventional | 2023-05-19 | Enrolling by invitation | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 trials available for pleconaril and Neonatal Sepsis
Article | Year |
---|---|
A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis.
Topics: Antiviral Agents; Double-Blind Method; Enterovirus; Enterovirus Infections; Female; Humans; Infant; | 2016 |
[A randomized, double-blind, placebo-controlled trial of pleconaril for the treatment of neonates with enterovirus sepsis].
Topics: Antiviral Agents; Double-Blind Method; Enterovirus Infections; Female; Humans; Infant, Newborn; Male | 2016 |